Market Update (NYSE:RTN): Raytheon completes lab testing on AMRAAM-ER, NASAMS integration

[PR Newswire] – TUCSON, Ariz., June 10, 2015 /PRNewswire/ — Raytheon Company (NYSE: RTN) has completed extensive lab testing on a new extended range variant of the combat-proven AMRAAM ® . The tests . . . → Read More: Market Update (NYSE:RTN): Raytheon completes lab testing on AMRAAM-ER, NASAMS integration Similar Articles: Company Update: Raytheon Co (NYSE:RTN) – Raytheon’s newest JSOW variant enters operational testing Company Update (NYSE:RTN): US Air Force completes operational testing on Raytheon’s MALD-J Stock Update (NYSE:RTN): Raytheon awarded $35 million U.S. Air Force aircraft integration and life cycle technical support contract